Skip to main content

Table 1 Correlation of antibiotic resistance between class 1 integron-positive and integron-negative of S.aureus

From: Variability in gene cassette patterns of class 1 and 2 integrons associated with multi drug resistance patterns in Staphylococcus aureus clinical isolates in Tehran-Iran

Antibiotics

All strains of S.aureus (n = 139)

Integron-positive isolates (n = 101)

Integron-negative isolates (n = 38)

P value

R

S

R

S

R

S

AK*

43 (31 %)

96 (69 %)

35 (34.7 %)

66 (25.3 %)

8 (21 %)

30 (79 %)

0.088

SXT*

38 (27.3 %)

101 (72.7 %)

34 (33.7 %)

67 (66.3 %)

4 (10.5 %)

34 (89.5 %)

0.004

C*

49 (32.3 %)

90 (64.7 %)

41 (40.6 %)

60 (59.4 %)

8 (21 %)

30 (79 %)

0.024

TE*

78 (56.1 %)

61 (43.9 %)

65 (64.4 %)

36 (35.6 %)

13 (34.2 %)

25 (65.8 %)

0.001

CIP*

56 (40.3 %)

83 (59.7 %)

49 (48.5 %)

52 (51.5 %)

7 (18.4 %)

31 (81.6 %)

0.001

GM*

76 (54.7 %)

63 (45.3 %)

68 (67.3 %)

33 (32.7 %)

8 (21 %)

30 (79 %)

<0.001

SPC*

86 (61.9 %)

53 (38.1 %)

73 (72.3 %)

28 (27.7 %)

13 (34.2 %)

25 (65.8 %)

<0.001

ATH*

69 (49.6 %)

70 (50.4 %)

62 (61.4 %)

39 (38.6 %)

7 (18.4 %)

31 (81.6 %)

<0.001

S*

75 (54 %)

64 (46 %)

61 (60.4 %)

40 (39.6 %)

14 (37 %)

24 (63 %)

0.011

GAT

44 (31.7 %)

95 (68.3 %)

32 (31.7 %)

69 (68.3 %)

12 (31.6 %)

26 (68.4 %)

0.581

OXA

104 (74.8 %)

35 (25.2 %)

76 (75.2 %)

25 (24.8 %)

28 (73.7 %)

10 (26.3 %)

0.505

PG

137 (98.6 %)

2 (1.4 %)

101 (100 %)

0 (0 %)

36 (94.7 %)

2 (5.3 %)

0.073

RP

43 (31 %)

96 (69 %)

31 (30.7 %)

70 (69.3 %)

12 (31.6 %)

26 (68.4)

0.537

LZD

24 (17.3 %)

115 (82.7 %)

20(19.8 %)

81 (80.2 %)

4 (10.5 %)

34 (89.5 %)

0.149

CD

84 (60.4 %)

55 (39.6 %)

65 (64.4 %)

36 (35.6 %)

19 (50 %)

19 (50 %)

0.089

E*

95 (68.3 %)

44 (31.7 %)

78 (77.2 %)

23(22.8 %)

17 (44.7 %)

21 (55.3 %)

<0.001

TN

66 (47.5 %)

73 (52.5 %)

46 (45.5 %)

55 (54.5 %)

20 (52.6 %)

18 (47.4 %)

0.289

LEV*

56 (40.3 %)

83 (59.7 %)

49 (48.5 %)

52 (51.5 %)

7 (18.7 %)

31 (81.6 %)

0.001

CRO*

71 (51.1 %)

68 (48.9 %)

66 (65.3 %)

35 (34.7 %)

5 (13.1 %)

33 (86.9 %)

<0.001

  1. *: significant values, AK Amikacin, SXT Trimethoprim- Sulfamethoxazole, C Chloramphenicol, TE Tetracycline, CIP Ciprofloxacin, GM Gentamicin, SPC Spectinomycin, ATH Azithromycine, S Streptomycin, GAT Gatifloxacin, OXA Oxacillin, PG Penicillin G, RP Rifampin, LZD Linezolid, CD Clindamycin, E Erythromycin, TN Tobramycin, LEV Levofloxacin, CRO Ceftriaxone; R Resistant, S sensitive